How do you make the world’s smartest toilet even smarter? Medic.Life invites tech partners to help

Provo — A Utah company’s planned demonstration of a virus-detecting smart toilet at the HIMSS Global Health Conference will not take place after the event was canceled over the coronavirus outbreak. But the quest is still on for Medic.Life ( to meet interested partners about adapting their biomedical instrumentation into the modular Medic.Lav platform before it becomes available in the next two years.

“Current events–including the cancellation of HIMSS–highlight just how critical it is to monitor real-time results about our health,” said Chad Adams, Medic.Life president and CEO. “The Medic.Lav represents decades of research to ensure consumer interactions are easy, convenient and fit naturally into their daily ‘life flow.’”

The proprietary sensor arrays make the Medic.Lav the world’s most advanced smart toilet. It gathers different health metrics passively during each bathroom visit and uses AI to analyze samples and generate trends for its users, who can monitor their progress with a secure mobile app. Medic.Life has more than 60 patents and another 90 patents pending for the technology associated with the toilet.

“Millions are prediabetic, hypertensive, have a chronic disease or a virus–and they don’t even know it,” said Chad Adams, Medic.Life CEO and president. “Medic is looking for the best and brightest biotech partners to be part of what will be a commonplace way to passively prevent disease and other health problems.”

The latest model of the Medic.Lav features a biosensor field-effect transistor or BioFET, which detects target molecules at very low concentrations, registering even one single particle or virus. The highly sensitive and versatile BioFET can identify thousands of biomarkers that indicate disease, infection or environmental exposure. For example, the sensor can measure concentrations of proteins, antigens as well as segments of DNA, RNA, and microRNA.

“Detecting viruses and other illnesses through urine sampling in public and private toilets will, in our opinion, become mandatory within five years,” said Adams. “Timely monitoring matters. Our goal is to help everyone become proactive rather than reactive with their health.”

Early adopters of this technology will likely be clinics; retail outlets; senior care and assisted living centers; pharma and lab science facilities; and other health care providers.

Medic.Life is still interested in meeting with potential biotech partners or investors to demonstrate the feasibility and capability of the smart toilet for analyzing waste using the miniaturized technology housed within the device. These capabilities open doors for adapting existing applications in medicine, general wellness, clinical compliance as well as pharmaceutical research and development.

The motion-activated Medic.Lav recognizes each user while gathering health metrics passively during each bathroom visit and uses AI to analyze and compare samples. Proprietary sensors provide information about the person’s weight, body fat, blood pressure as well as signs leading to diabetes, hypertension, cardiovascular disease, chronic kidney disease, and seven more major health risk areas.


Medic.Life planned to exhibit the Medic.Lav at the 2020 HIMSS Global Health Conference on March 9-13 in Orlando, Florida. The conference was canceled because organizers decided the risk of spreading the coronavirus was too great. Those who planned to attend HIMSS can still visit to get more information or arrange to see a demonstration of the Medic.Lav at the Medic.Life headquarters in Provo, Utah.

About Medic Life

Medic.Life is located in Provo, Utah, where all Medic product development and innovation takes place. The company is creating technology with the idea that “Prevention is better than a cure.” The Medic team started developing its toilet-based technology in 1999 and has more than 100 patents and patent applications related to improving health monitoring and preventable care. Medic.Life is a member of the Hall Labs portfolio of companies in the Provo Opportunity Zone, which has been named as one of the top three in the U.S. for tax-advantaged opportunities. For more information visit